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Human nectin-1 (HveC, Prr1), a member of the immunoglobulin superfamily and a receptor for the entry of herpes simplex
viruses 1 and 2 (HSV-1, HSV-2), pseudorabies virus (PRV), and bovine herpesvirus 1 (BHV-1), binds to viral gD. For HSV-1,
HSV-2, and PRV, the gD-binding region of nectin-1 has been localized to the N-terminal V-like domain. To determine whether
the two C-like domains of nectin-1 influenced gD binding and entry activity, genes encoding chimeric proteins were
constructed. Portions of nectin-1 were replaced with homologous regions from nectin-2 (HveB, Prr2), a related protein with
ability to mediate the entry of PRV, HSV-2, and Rid mutants of HSV-1, but not HSV-1 or BHV-1. Also, one or more domains of
nectin-1 were fused to the two membrane-proximal Ig domains of CD4, a protein with no herpesvirus entry or gD-binding
activity. The chimeric proteins were expressed in Chinese hamster ovary cells, which normally lack alphaherpesvirus entry
receptors, and detected on the cell surface by one or more anti-nectin-1 monoclonal antibodies. One chimeric protein
(nectin-1 amino acids 1–124 fused to CD4) failed to bind to soluble forms of HSV-1, HSV-2, PRV, and BHV-1 gD and, as
expected, also failed to mediate entry of the viruses from which these gDs were derived. The other chimeric receptors bound
all forms of gD. Some mediated the entry of all the viruses tested but others mediated entry of some but not all the viruses.
We conclude that binding of gD to the nectin-1 V domain is not sufficient for entry activity, that there are structural
requirements for entry activity independent of gD binding, and that these requirements are different for the several
alphaherpesviruses that can use nectin-1 as a receptor. © 2001 Academic Press
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Certain alphaherpesviruses, such as herpes simplex
viruses 1 and 2 (HSV-1 and HSV-2), porcine pseudora-
bies virus (PRV), and bovine herpesvirus 1 (BHV-1), can
bind to cells through an initial interaction of viral gC or gB
with heparan sulfate chains on cell surface proteogly-
cans. Following this binding, entry requires an interac-
tion of viral gD with any one of several cell surface
coreceptors. This interaction somehow triggers fusion
between the viral envelope and cell membrane, an event
which requires the activities of viral gB, gH, and gL, as
well as gD and its receptor (reviewed by Spear, 1993;
Spear et al., 2000).
Human nectin-1 (Takahashi et al., 1999), also known
as herpesvirus entry protein C (HveC) (Geraghty et al.,
1998) or poliovirus receptor-related protein 1 (Prr1)
(Lopez et al., 1995), is one of the several gD-binding entry
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366receptors for HSV-1 and HSV-2 and can also mediate
entry of PRV and BHV-1 as well as bind to PRV and BHV-1
forms of gD (Cocchi et al., 1998a, 1998b; Connolly et al.,
2001; Geraghty et al., 2000, 1998; Krummenacher et al.,
1998). Nectin-1 is a member of the immunoglobulin (Ig)
superfamily and is highly conserved in mammals, at
least in the Ig-like domains of the ectodomain. Pairwise
comparisons of the amino acid sequences of human,
monkey, pig, cow, mouse, and hamster nectin-1 revealed
90–98% identity in the ectodomain (Menotti et al., 2000;
Milne et al., 2001; Shukla et al., 2000). In addition, mouse
and pig forms of nectin-1 have been shown to mediate
the entry of HSV-1, HSV-2, PRV, and BHV-1 and to bind
various forms of gD encoded by these viruses (Menotti et
al., 2000; Milne et al., 2001; Shukla et al., 2000). This
ability of human and animal alphaherpesvirus gDs to
recognize conserved features of the human and animal
forms of nectin-1 explains in part their broad host ranges
for entry and previous observations that expression of
gD in certain cell types could interfere with entry of the
homologous as well as heterologous alphaherpesvi-
ruses (Chase et al., 1990, 1993; Geraghty et al., 2000;
Petrovskis et al., 1988).Nectin-1 is expressed in a variety of cell types, most
notably in epithelial cells and neurons (Cocchi et al.,
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367HERPESVIRUS ENTRY VIA NECTIN-1 CHIMERIC PROTEINS1998b; Geraghty et al., 1998; Shukla et al., 2000). Two
soforms, nectin-1a and nectin-1b, share identical
ectodomains and herpesvirus entry activity but differ in
their membrane spans and cytoplasmic domains due to
differential splicing of the gene transcript (Cocchi et al.,
1998b; Geraghty et al., 1998). Both nectin-1a and nec-
in-1b can engage in homotypic interactions through
heir ectodomains and nectin-1a localizes to regions of
adherin-based adherens junctions in epithelial cells
hrough interactions of its cytoplasmic tail with PDZ do-
ains in afadin, an actin-binding protein (Miyahara et al.,
000; Tachibana et al., 2000; Takahashi et al., 1999).
The ectodomain of nectin-1 is composed of an N-
erminal V-like domain and two C-like domains (Fig. 1).
everal lines of evidence indicate that, for all the viruses
entioned above, the gD-binding region of nectin-1 is
ocalized to the V-like domain. Soluble forms of HSV-1,
SV-2, and PRV gD bind efficiently to truncated or de-
eted forms of nectin-1 retaining only the V-like region
nd compete with each other for this binding (Cocchi et
l., 1998a; Connolly et al., 2001; Krummenacher et al.,
999). Monoclonal antibodies whose epitopes are lo-
ated in the V domain can block the binding of HSV gD
nd infection (Cocchi et al., 1998a; Krummenacher et al.,
000). Also, nectin-1 deleted for the two C-like domains
etains the ability to mediate HSV entry, albeit with re-
uced efficiency (Cocchi et al., 1998a). Finally, expres-
ion of full-length gD encoded by HSV-1, HSV-2, PRV, or
HV-1 can interfere with entry of any of these viruses into
ells expressing only nectin-1 as receptor, additional
vidence that the different forms of gD compete for
nteraction with nectin-1 (Geraghty et al., 2000).
To determine whether the two C-like domains of nec-
in-1 influenced gD binding and entry activity, genes
ncoding chimeric proteins were constructed. In one set
f chimeras, portions of nectin-1 were replaced with
omologous regions from nectin-2 (HveB, Prr2), a related
rotein with ability to mediate the entry of PRV, HSV-2,
nd Rid mutants of HSV-1, but not wild-type HSV-1 or
HV-1 (Lopez et al., 2000; Warner et al., 1998). Rid mu-
ants of HSV-1 have amino acid substitutions at position
7 in gD (Dean et al., 1994) that result in acquired ability
o use nectin-2 for entry without effect on the use of
ectin-1 for entry (Geraghty et al., 1998; Montgomery et
l., 1996; Warner et al., 1998). In the second set of chi-
eras, one or more domains of nectin-1 were fused to
he two membrane-proximal Ig domains of CD4 (Wang
nd Springer, 1998), a protein with no herpesvirus entry
ctivity and no detectable ability to bind to HSV gD
Whitbeck et al., 1997). One of the chimeric molecules
ailed to bind to soluble forms of gD encoded by any of
he alphaherpesviruses tested and also failed to mediate
heir entry. The other chimeric molecules bound to all the
Ds but two of them failed to exhibit the predicted viral
ntry activities. The results indicate that binding of gD is
ot sufficient for entry activity, that there are structural
hequirements for entry independent of gD binding, and
hat these requirements are different for the various
lphaherpesviruses tested.
RESULTS
onstruction of plasmids encoding nectin-1 chimeras
Figure 1A presents diagrams of the chimeric mole-
ules formed by replacing domains of nectin-1a with
FIG. 1. Domain composition of nectin-1/nectin-2a chimeras and nec-
tin-1/CD4 chimeras. (A) Nectin-1/nectin-2a chimeras in which regions
of nectin-2a (thin gray lines) were replaced with the homologous
egions from nectin-1 (thick black lines). The names given to the
himeras indicate whether the first, second, and third Ig-like domains
atch the sequence of nectin-1 or nectin-2. The name 1*/2/2 indicates
hat most of the nectin-2 V domain, up to the second conserved Cys,
as replaced with the nectin-1 sequence, whereas, in 1/2/2, all of the
ectin-2 V domain was replaced with the nectin-1 sequence. (B) Nectin-
/CD4 chimeras in which one (1/4/4), two (/1/1/4/4), or all three (1/1/
/4/4) of the Ig domains from nectin-1 were fused to the hinge region
ust upstream of the two membrane-proximal Ig domains of CD4. In
himera 1D/4/4 only part of the nectin-1 V domain, up to and including
he second conserved Cys, was fused to CD4. Nectin-1 sequence is
ndicated by the thick black lines and CD4 sequence by the thin gray
ines. The characteristic disulfide bonds predicted to be present in
ost Ig-like domains are indicated by “S-S.” V, variable-like domain; C,
onstant-like domain; D, Ig-like domain. Drawing not to scale.omologous domains of the related nectin-2a. Although
the nectin-1a open reading frame is larger than that for
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368 GERAGHTY ET AL.nectin-2a (517 amino acids compared with 479 amino
acids) and alignment reveals only about 35% identity in
the ectodomains, the Ig domain organization is similar
for the two proteins, so that chimeras could be con-
structed to retain the domain organization of both paren-
tal molecules. Chimera 1*/2/2 has most of the V-like
domain of nectin-1 joined after the second conserved
Cys to nectin-2a at the equivalent amino acid. Chimera
/2/2 has the entire V-like domain of nectin-1 joined to
he first C-like domain of nectin-2a midway between the
second and third conserved Cys residues. Chimera
1/1*/2 has the entire V-like domain and most of the first
C-like domain of nectin-1 joined after the fourth con-
served Cys to nectin-2a at the equivalent amino acid.
igure 1B depicts the nectin-1 chimeras with CD4 in
hich one (1/4/4), two (1/1/4/4), or three (1/1/1/4/4) of the
g domains of nectin-1 were fused to a hinge region in
D4 located N-terminal to the two membrane-proximal
g domains. Chimera 1D/4/4 differs from chimera 1/4/4 in
hat a portion of the V-like domain of nectin-1 was de-
eted, namely, the amino acids following the second
onserved Cys.
ell surface expression and conformation of the
ectin-1 chimeric receptors
To determine whether the chimeric proteins were ex-
ressed in cells and translocated to the cell surface with
etention of gD-binding activity, Chinese hamster ovary
CHO) cells were transfected with plasmids expressing
ull-length nectin-1a or the various chimeric proteins and
hen tested by CELISA for the binding of monoclonal
ntibodies (mAbs) specific for nectin-1 and for the bind-
ng of soluble forms of gD.
One of the mAbs (R1.302) recognizes a conformational
pitope within the V domain of nectin-1 (Cocchi et al.,
998a; Krummenacher et al., 2000). The others can bind
o native or denatured nectin-1 and their epitopes have
een mapped, by use of overlapping synthetic peptides,
o sequences in the V domain from amino acids 70
hrough 114 (Krummenacher et al., 2000). Three of the
Abs, R1.302, CK6, and CK8, can compete with HSV-1 gD
or binding to nectin-1 (Cocchi et al., 1998a; Krummen-
acher et al., 2000). Soluble forms of HSV-1, HSV-1(Rid1),
HSV-2, PRV, and BHV-1 gD were produced from plasmids
in which sequences encoding the ectodomain of each
viral protein were fused to sequences encoding the Fc
region of rabbit immunoglobulin. For the CELISA, trans-
fected cells were washed and incubated with the mAbs
or gD:Fcs and then washed again and fixed prior to
addition of secondary antibody and the detection system.
For all the chimeric receptors except one, as de-
scribed more fully below, we found that the relative
amounts of mAb R1.302 and gD:Fc bound to chimera in
comparison with those bound to nectin-1a were similar,
reflecting the relative amounts of properly folded V do-main present at the cell surface. Figure 2 shows the
concentration-dependent binding of R1.302 and HSV-1
gD:Fc to CHO cells transfected with plasmids expressing
nectin-1a and two representative chimeric receptors.
Reproducibly, we have found that both ligands bound as
well or better to cells expressing chimera 1*/2/2 (and the
other nectin-1/nectin-2 chimeras, as shown below) as to
cells expressing nectin-1a, indicating that cell surface
xpression of these chimeras and certain critical as-
ects of their conformation in the V domain are probably
early equivalent to that of nectin-1a. On the other hand,
both ligands reproducibly bound somewhat less well to
cells expressing chimera 1/1/1/4/4 and some of the other
nectin-1/CD4 chimeras, indicating either somewhat re-
duced levels of expression or reduced affinity for the
ligands. The results shown below for all the chimeric
receptors depict the levels of various mAbs or gD:Fcs
bound at saturating concentrations of ligand.
The results shown in Fig. 3 demonstrate that R1.302,
CK6, and CK8 bound to cells expressing nectin-1a or the
nectin-1/nectin-2a chimeras equally well, suggesting
that none of these chimeras was impaired in expression,
overall folding of the gD-binding region in the nectin-1 V
domain, or translocation to the cell surface. The mAbs
that bind to linear epitopes encompassing amino acids
70 to 114 (CK1, CK5, CK7, CK10, CK11), mostly in regions
flanking the CK6 and CK8 epitopes, could bind to chime-
ras 1/2/2 and 1/1*/2 as well as or better than to nectin-1a
but had reduced binding to chimera 1*/2/2, suggesting
that this chimera did not have precisely that same con-
FIG. 2. Binding of an anti-nectin-1 mAb and wild-type HSV-1 gD:Fc to
CHO cells expressing nectin-1 or two of the chimeric receptors. CHO
cells were transfected with plasmids expressing the receptors indi-
cated, replated in 96-well plates, and incubated in triplicate with serial
dilutions of the mAb R1.302 or HSV-1 gD:Fc. The cells were then
washed and fixed and incubated with biotinylated secondary antibod-
ies and an avidin–HRP detection system. Similar results were obtained
in two independent experiments done as indicated here and in numer-
ous experiments done with single concentrations of mAb or gD:Fc
known to give maximal binding. The symbols and error bars are the
means and standard deviations, respectively, of triplicate determina-
tions. The absence of error bars for mean values given in Figs. 2–7 is
due to standard deviations too small to generate a visible error bar.formation in the V domain as authentic nectin-1a.
Figure 4 presents similar results for the nectin-1/CD4
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369HERPESVIRUS ENTRY VIA NECTIN-1 CHIMERIC PROTEINSchimeric molecules. At least five of the mAbs that rec-
ognize linear epitopes (CK1, CK5, CK7, CK10, and CK11)
bound almost as well to three of the chimeras (1D/4/4,
/4/4, 1/1/1/4/4) as to nectin-1a, indicating that there is
ear-equivalent expression and translocation to the cell
urface. Chimera 1/1/4/4 bound all of the antibodies at
0–75% of the amounts bound to nectin-1a, probably
ecause this chimera exhibited somewhat reduced lev-
ls of expression or transport to the cell surface. The
ntibody that competes best with gD for binding to nec-
in-1 (R1.302) bound well to chimeras 1/4/4, 1/1/1/4/4,
nd probably also to 1/1/4/4 (assuming less cell surface
xpression) but failed to bind to chimera 1D/4/4, sug-
esting that the gD-binding region is not properly folded.
FIG. 3. Binding of anti-nectin-1 mAbs to CHO cells expressing nec-
tin-1a or the nectin-1/nectin-2a chimeric receptors. CHO-K1 cells were
transfected with plasmids expressing the molecules indicated or with
control plasmid and then replated in 96-well plates. The cells were
incubated in triplicate with the mAbs indicated, at 1:500 dilutions of
ascites fluid. The cells were then washed and fixed and the bound
mAbs detected as described in the text and the legend to Fig. 2. Within
each experiment, the means of the triplicate determinations were
expressed as a percentage of the mean obtained for the nectin-1a
transfection (which ranged from 0.134 to 0.198 OD at 370 nm). The
experiments were performed at least three times and the mean values
plus standard deviations for the combined results are depicted. Each
panel shows the results obtained with the mAb indicated. CK7 and
CK10 (in parentheses) bind to epitopes that overlap those of CK11 and
CK1, respectively (Krummenacher et al., 2000), and gave results very
similar to those shown for CK11 and CK1.K6 and CK8, which also bind to a region of nectin-1
verlapping the gD-binding site, had reduced binding toll of the chimeras, particularly 1D/4/4 and 1/1/4/4/, but
xhibited better binding to the former chimera than did
1.302. These results, taken together, suggest that chi-
eras 1/4/4 and 1/1/1/4/4 were expressed well, as-
umed a nearly normal conformation in the nectin-1 V
omain, and were transported to the cell surface, that
/1/4/4 was not so well expressed or transported, and
hat 1D/4/4 was probably improperly folded, particularly
n the gD-binding region.
To test directly for gD-binding activity, CHO cells were
ransfected with plasmids expressing nectin-1a or each
of the chimeric receptors and then incubated with gD:Fcs
derived from HSV-1, HSV-1(Rid1), HSV-2, PRV, and BHV-1.
After this incubation, the live cells were washed and
fixed prior to addition of a secondary anti-rabbit antibody
and a detection system for CELISA. The results shown in
Fig. 5 demonstrate that all forms of gD:Fc bound as well
or better to the nectin-1/nectin-2a chimeras as to nec-
tin-1a (data not shown for HSV-2 gD:Fc). All forms of
gD:Fc also bound to two of the nectin-1/CD4 chimeras,
namely, 1/4/4 and 1/1/1/4/4, at about 70–95% of the levels
bound to nectin-1a. The reduced binding of the gD:Fcs to
himera 1/1/4/4 is consistent with the reduced binding of
FIG. 4. Binding of anti-nectin-1 mAbs to CHO cells expressing nec-
tin-1a or the nectin-1/CD4 chimeric receptors. CHO-K1 cells were
transfected with plasmids expressing the molecules indicated or with
control plasmid and then replated in 96-well plates. The cells were
incubated in triplicate with the mAbs indicated. The mAb-binding assay
was performed and the results are presented exactly as described in
the legend to Fig. 3. The positive control values for binding of the mAbs
to cells expressing nectin-1a ranged from 0.136 to 0.247 OD at 370 nm.
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370 GERAGHTY ET AL.all the mAbs, probably resulting from reduced cell sur-
face expression. None of the gD:Fcs was capable of
binding to chimera 1D/4/4 at levels above background,
consistent with the inability of R1.302 to bind. These
findings, coupled with the fact that other mAbs bound
well to chimera 1D/4/4, indicate that this protein is ex-
pressed on the cell surface in amounts comparable to
the other chimeras but is misfolded in the V domain so
FIG. 5. Binding of various gD:Fcs to CHO cells expressing parental or
chimeric receptors. CHO-K1 cells were transfected with plasmids ex-
pressing the molecules indicated or with control DNA and replated in
96-well plates. The next day the cells were incubated in triplicate with
the various forms of alphaherpesvirus gD:Fc indicated and then
washed and fixed and the bound gD:Fcs detected as indicated in the
text and legend to Fig. 2. Within each experiment, the means of the
triplicate determinations were expressed as a percentage of the mean
obtained for the nectin-1a transfection (which ranged from 0.2 to 1.6 OD
at 370 nm). The experiments were performed at least three times and
the mean values plus standard deviations for the combined results are
depicted. Results similar to those shown for HSV-1 gD:Fc were also
obtained with HSV-2 gD:Fc (data not shown).that gD cannot bind. We recognize that the absence of
significant binding of HSV-1(Rid1) and PRV gD:Fcs to Tparental nectin-2a is inconsistent with the ability of this
eceptor to mediate the entry of HSV-1(Rid1) and PRV.
here are probably at least two explanations for this
nomaly. The affinity of binding of appropriate forms of
oluble gD to nectin-2a appears to be low (Connolly et
al., 2001; Lopez et al., 2000). Also, although both nectin-1
and nectin-2 engage in homotypic interactions through
their V domains (Miyahara et al., 2000), preliminary evi-
dence suggests that nectin-2a, but not nectin-1a, quan-
titatively localizes at regions of cell contact in transfected
CHO cells (M. Yoon and P. G. Spear, unpublished stud-
ies). Soluble gD, but not virus, may fail to gain access to
the V domain of nectin-2a under these conditions.
Entry activities of the nectin-1 chimeric receptors
Because CHO cells are normally resistant to entry of
the alphaherpesviruses under study here, they could be
used to assess the entry activities of the chimeric recep-
tors as well as their expression and cell surface display
of binding determinants. CHO cells were transfected
with nectin-1a, nectin-2a, CD4, or each of the chimeric
molecules and then tested for susceptibility of the cells
to entry of wild-type HSV-1, HSV-1(Rid1), PRV, and BHV-1.
The transfected cells were exposed to various concen-
trations of recombinant forms of these viruses, each
expressing b-galactosidase from an inserted reporter
gene. Enzyme activity was quantitated at 6 h after the
addition of virus to measure the gene expression occur-
ring immediately after viral entry.
Results obtained with the nectin-1/nectin-2a chimeras
re shown in Fig. 6. As expected, nectin-1a mediated
entry of all the viruses tested, whereas nectin-2a medi-
ted entry of PRV and HSV-1(Rid1) only. Replacement of
he entire V domain or more of nectin-2a with the homol-
ogous regions from nectin-1, in chimeras 1/2/2 and
1/1*/2, yielded receptors capable of mediating the entry
of all four viruses with efficiencies as high as or higher
than that observed for nectin-1a. Thus, the V domain of
ectin-1 is all that is required for full entry activity for all
our alphaherpesviruses, at least when this domain is
inked to the two C domains of either nectin-1a or nectin-
a. A previous report documented the importance of the
ectin-1 V domain for HSV-1 entry by showing that at
east some entry activity was retained by a form of
ectin-1b from which both C domains had been deleted
(Cocchi et al., 1998a). The third nectin-1/nectin-2a chi-
mera, 1*/2/2, exhibited full entry activity for BHV-1 but
was unexpectedly impaired in ability to mediate entry of
HSV-1 and HSV-1(Rid1), particularly at low doses of virus,
despite the fact that chimera 1*/2/2 bound all forms of
gD:Fc very well (Fig. 5) and bound HSV-1 gD:Fc as well
as did nectin-1a at all concentrations tested (Fig. 2).
hus, the amino acids C-terminal of the second con-
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371HERPESVIRUS ENTRY VIA NECTIN-1 CHIMERIC PROTEINSserved Cys in nectin-1a, in a region forming part of the
putative G and G9 strands of the V-like Ig fold (Krummen-
acher et al., 2000), appear to influence entry of HSV-1. It
should be noted that all the parental and chimeric re-
ceptors mediated efficient entry of PRV, which provided
assurance that critical features important to the activity
of each parental molecule had not been destroyed by the
gene fusions.
Results obtained with the nectin-1/CD4 chimeras are
shown in Fig. 7. Chimera 1D/4/4 failed to mediate entry of
any of the viruses tested, consistent with its inability to
bind any of the gD:Fcs (Fig. 5) and with the body of
evidence that gD binding is associated with alphaher-
pesvirus entry activity (reviewed by Spear et al., 2000).
The other chimeras, 1/4/4, 1/1/4/4, and 1/1/1/4/4, were
almost as efficient as nectin-1a at mediating entry of
RV. Chimera 1/1/1/4/4, however, failed to mediate entry
f any of the other viruses despite its ability to bind the
D:Fcs derived from these viruses. Chimeras 1/4/4 and
/1/4/4 had equivalent entry activities for the HSV-1
trains but were somewhat less efficient than nectin-1a.
Chimera 1/4/4 had partial activity for entry of BHV-1, while
1/1/4/4 was much less effective. Thus, PRV, HSV-1, and
BHV-1 differ in ability to use these chimeras for entry
despite the similarity in results obtained when the gD:
FIG. 6. Alphaherpesvirus entry activity of the nectin-1/nectin-2a chi-
meric receptors. CHO-K1 cells were transfected with plasmids ex-
pressing the proteins indicated or with a control plasmid and then
replated in 96-well plates. The next day the cells were inoculated with
HSV-1, HSV-1(Rid1), PRV, or BHV-1 recombinants expressing b-galac-
osidase. Six hours after inoculation, cells were lysed and b-galacto-
idase activity was determined as a measure of virus entry. The assays
ere performed in triplicate and repeated three times with similar
esults. The mean values plus standard deviations for a representative
xperiment are depicted.Fcs derived from each virus were tested for binding to
the chimeric receptors (Fig. 5).DISCUSSION
An important conclusion of this study is that binding of
alphaherpesvirus gD to a cell surface receptor does not
necessarily result in viral entry. Two of the chimeric
receptors, 1*/2/2 and 1/1/1/4/4, bound to all forms of
alphaherpesvirus gD available for this study, apparently
as well as did nectin-1a, but yet 1*/2/2 was impaired for
he entry of HSV-1 and 1/1/1/4/4 failed to mediate entry of
SV-1 or BHV. Also, the ability of these chimeric recep-
ors to mediate alphaherpesvirus entry was highly virus-
pecific. Chimera 1/1/1/4/4 was a fully functional entry
eceptor for PRV, as was 1*/2/2 for PRV, and BHV-1.
Comparisons of mAb binding to nectin-1a and chime-
ras 1*/2/2 and 1/2/2 revealed that 1*/2/2 is altered in
conformation in the V domain even though it is appar-
ently not altered in gD-binding activity (Figs. 2 and 5).
Although the mAbs that can compete with gD for binding
to the V domain of nectin-1 exhibited similar levels of
binding to nectin-1 and both chimeras, other mAbs
whose epitopes have been mapped to a region spanning
amino acids 70–114 had reduced binding to chimera
1*/2/2. The differences in amino acid sequence between
chimeras 1*/2/2 and 1/2/2 lie outside the epitopes for
these mAbs, between amino acids 131 and 143, as
shown in Fig. 8. This region encompasses the putative G
and G9 b-strands of the V domain extending to the
unction between the V and C domains. A site for the
ddition of an N-linked glycan is found in this region of
/2/2 but is absent from 1*/2/2. Moreover, differences in
he amino acid sequence shown in Fig. 8 are likely to
ffect interaction with other b-strands. These differences
ust influence the binding of some of the mAbs and the
FIG. 7. Alphaherpesvirus entry activity of the nectin-1/CD4 chimeric
receptors. CHO-K1 cells were transfected with plasmids expressing the
proteins indicated or with a control plasmid and then replated in
96-well plates. The next day viral entry assays were performed and the
results are presented as described in the legend to Fig. 6.
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372 GERAGHTY ET AL.ability of 1*/2/2 to serve as an efficient entry receptor for
HSV-1, but have little or no effect on binding of all the
gD:Fcs tested, on binding of mAbs that compete with gD
for binding, or on entry activity for PRV or BHV-1. Thus,
the entry activity of a receptor depends not just on
binding of gD but on structural features of the receptor in
addition to the gD-binding domain.
Possibly, binding of gD induces conformational
changes in both gD and receptor, postbinding events
that depend in part upon the region altered in chimera
1*/2/2 and contribute to activation of the fusogenic ac-
tivity of the viral glycoproteins required for entry. Alter-
natively, there may be multiple gD-binding sites on the
nectin-1 V domain necessary to promote efficient viral
entry. The CELISA assay may detect an initial or simple
binding of the soluble gD:Fc to the V-like domain of
nectin-1a and not distinguish between that initial inter-
ction and a more complex interaction with gD that is
equired for efficient virus entry. Whatever the explana-
ion, our results suggest that chimera 1/2/2 has all the
eatures of nectin-1 that make it a functional receptor for
he viruses studied here, whereas 1*/2/2 has the appro-
riate gD-binding domain for all these viruses and other
eatures required for postbinding events leading to entry
f PRV and BHV-1, but not HSV-1, or has features that
mpede the entry of HSV-1.
The inability of chimera 1D/4/4 to mediate entry of any
f the alphaherpesviruses is explained readily by its
ailure to bind any of the alphaherpesvirus gDs. Deletion
f the C-terminal portion of the V domain that extends
rom the second conserved Cys (Fig. 8) must have
aused misfolding of the V domain so that gD binding
as lost. Comparisons of mAb binding and gD:Fc bind-
ng to nectin-1a and chimera 1/1/1/4/4 suggest that the V
domain of this chimera is properly folded and is func-
tional for binding to all the alphaherpesvirus gD:Fcs
tested here. Yet this molecule cannot serve as an entry
FIG. 8. Differences in amino acid sequence between the nectin-1/
ectin-2a chimeras, 1*/2/2 and 1/2/2, and the nectin-1/CD4 chimeras,
1/4/4 and 1D/4/4. Numbering is from the initiator Met. Portions of each
chimera derived from nectin-2a (top set) are underlined and portions
erived from CD4 (bottom set) are in bold-faced type. Positions with
dentical amino acids are marked with double dots. The potential site
or addition of an N-linked glycan in nectin-1 is shaded.receptor for HSV-1 or BHV-1 even though it is functional
for PRV entry. Because nearly the entire ectodomain of
h
tnectin-1 is fused to CD4 in this chimera, it seems likely
that conformation of the nectin-1 V domain is preserved.
We cannot be certain how far this molecule extends from
the plasma membrane but perhaps it extends too far to
be an efficient entry receptor for some of the alphaher-
pesviruses. If distance of the nectin-1 gD-binding region
from the plasma membrane is the explanation, why is
PRV able to use chimera 1/1/1/4/4 for entry? There is as
yet no answer to this question but it should be noted that
significant amounts of PRV gD:Fc can bind to CHO cells
even in the absence of transfected entry receptors (Fig.
5). Although CHO cells are resistant to PRV entry in the
absence of a transfected entry receptor, it is possible
that PRV entry can result from the synergistic effects of
gD binding to a putative endogenous CHO receptor as
well as to 1/1/1/4/4.
The results presented here confirm and extend previ-
ous reports that localized the binding sites for HSV-1,
HSV-2, and PRV gDs to the V domain of nectin-1 (Cocchi
et al., 1998a; Connolly et al., 2001; Krummenacher et al.,
2000, 1999). We show here that the binding site for BHV-1
gD is also localized to the V domain. The binding of
HSV-1, HSV-2, PRV, and BHV-1 gD:Fcs to chimeric recep-
tors depended only on the presence of the V domain
from nectin-1. Moreover, each of the alphaherpesvirus
gDs compete with each other for binding to nectin-1a
(Connolly et al., 2001; Geraghty et al., 2000). Thus, the
regions on nectin-1 to which the alphaherpesvirus gDs
bind are overlapping but not necessarily identical.
The two isoforms of nectin-1 differ in their transmem-
brane domains and cytoplasmic tails but are identical in
their Ig-like domains. Both are functional for alphaher-
pesvirus entry and most of the nectin-1/nectin-2 and
nectin-1/CD4 chimeras described here are also func-
tional for entry. Therefore, the structure of the transmem-
brane region and cytoplasmic tail is not important for
alphaherpesvirus entry. In fact, deletion of the cytoplas-
mic tail from nectin-1a has no effect on entry activity (R. J.
Geraghty and P.G. Spear, unpublished results). The fea-
tures of nectin-1 that are important for alphaherpesvirus
entry include the gD-binding region of the V domain and
a region near the C terminus of the V domain in which
certain amino acid substitutions do not affect gD binding
but impair HSV-1 entry. It appears that molecules carry-
ing the nectin-1 V domain work best as entry receptors
when the V domain is fused to two Ig-like domains, as in
nectin-1a itself or chimeras 1/2/2 or 1/1*/2 or less well in
/4/4. Deletion of the two C domains of nectin-1 reduced
he efficiency of entry (Cocchi et al., 1998a), as did gen-
ration of chimeras with the nectin-1 V domain fused to
Ig-like domains. Because the amino acid sequence
nd alphaherpesvirus entry activity of nectin-1 are highly
onserved among mammals, we predict that the struc-
ural requirements for alphaherpesvirus entry defined
ere for human nectin-1 will also be relevant to some of
he animal forms of nectin-1.
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Cells and viruses
CHO-K1 cells were provided by J. Esko (University of
California, San Diego) and were grown as previously
described (Montgomery et al., 1996). PEAK cells (Edge
Biosystems), which are human embryonic kidney cells
that express SV40 T antigen, were grown in DMEM
supplemented with 10% fetal bovine serum and antibiot-
ics. The b-galactosidase–reporter viruses have been de-
cribed previously, HSV-1(KOS)tk12 and HSV-1(KOS)Rid1/
k12 (Warner et al., 1998), PRV(Kaplan)gH2 (Babic et al.,
1996) provided by T. Mettenleiter (Federal Research Cen-
tre for Virus Diseases of Animals, Insel Riems, Germany),
and BHV-1(Cooper)v4a (Miller et al., 1995) provided by L.
Bello (University of Pennsylvania). The HSV strains were
propagated and titered on Vero cells, PRV(Kaplan)gH2
was propagated and titered on gH-expressing VeroSW78
cells, and BHV-1(Cooper)v4a was propagated and titered
on MDBK cells.
Plasmids
All expression plasmids used the human cytomegalo-
virus (CMV) immediate-early promoter for efficient pro-
tein expression in eukaryotic cells. The nucleotide se-
quence was determined for relevant portions of all plas-
mids constructed using PCR, to guard against mutations
arising during amplification. All PCR amplifications were
performed using a step-down procedure (Geraghty et al.,
1998). The CD4 expression plasmid pBG53 was con-
structed by amplifying the CD4 open reading frame in
pT4B (Maddon et al., 1985) (obtained through the AIDS
Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH) with primers 59CD4 (59CGGGATCCAT-
GAACCGGGGAGTCCCTTTTAGG) and 39CD4 (59CGTG-
GATCCGAAATGGGGCTACATGTCTTCTG), digesting the
product with BamHI, and ligating the fragment into the
expression vector pMN104 (Montgomery et al., 1996)
digested with BamHI. The templates for the PCR reac-
tions described below were pBG38 (Geraghty et al.,
1998) to generate nectin-1a sequences, pMW20 (Warner
t al., 1998) to generate nectin-2a sequences, and pT4B
o generate CD4 sequences.
Plasmids expressing receptor chimeras. The receptor
himera open reading frames were created by PCR.
riefly, for each chimera the nectin-1a sequences and
he nectin-2a or CD4 sequences were amplified in sep-
arate reactions. One of the primers used in the nectin-1a
amplifications contained nucleotides (18 to 20 bases) on
its 59 end that matched nectin-2a or CD4 sequences.
imilarly, one of the primers used in the nectin-2a or CD4
amplifications had nucleotides on its 59 end that
matched the appropriate nectin-1a sequence. The re-pective amplification products were purified and com-
ined in a final PCR reaction using the upstream flankingrimer from the nectin-1a reaction and the downstream
lanking primer from the nectin-2a or CD4 reaction. This
product was then purified, digested with restriction en-
donucleases, and inserted into pcDNA3 under control of
the CMV promoter. The plasmid names and amino acid
composition for each chimera are indicated in Table 1.
Soluble gD-expressing plasmids. The plasmid ex-
pressing the HSV-1(KOS) gD:Fc fusion protein, pBG64,
has been described. To create the HSV-1(KOS)Rid1
gD:Fc expression plasmid named pAF1, pCJ1 (Geraghty
et al., 2000) was digested with HindIII and PpuMI and the
fragment containing the portion of the gD gene encom-
passing the Rid1 mutation was ligated to the larger
fragment obtained by digesting pBG64 with HindIII and
PpuMI. To create the PRV, BHV-1, and HSV-2 gD:Fc ex-
pression plasmids, each gD extracellular domain was
amplified using PCR, and the PCR product digested with
HindIII and EcoRI and ligated to the larger fragment
obtained by digesting pBG64 with HindIII and EcoRI,
such that the HSV-1(KOS) gD ectodomain was replaced
by the appropriate gD ectodomain from another virus,
fused in frame to the rabbit IgG Fc region. The primers
used to create the PRV gD:Fc expression plasmid,
pBG73, were PgDFc1 (59ATGAATTCGCGGCTC-
CGCGGGCTGCGGC) and PRVHIII (59AGCTAAGCTTAT-
GCTGCTCGCAGCGCTATT) and the template was the
PRV gD expression plasmid, pCMVgD (Gerdts et al.,
1997). The primers used to create the BHV-1 gD:Fc ex-
pression plasmid pBG74 were BgDFc1 (59ATGAATTCG-
CACGGCGTCGGGGGCCGCG) and BHVHIII (59TAGG-
GAGACCCAAGCTTATGCAAGGGCCGACA) and the tem-
plate was the BHV-1 gD expression plasmid, pBG58
(Geraghty et al., 2000). The primers used to create the
HSV-2 gD:Fc-expressing plasmid, pBG75, were Hind-
IIIbest (59CAAATGGGCGGTAGGCGTGTACGGTGGGAG)
and 2gDRI (59ATGAATTCGGATGATCAGGCCCGGGT-
TGC) and the template was pWM46. The plasmid
pWM46 was created by digesting the HSV-2(333) gD-
containing plasmid pWW65 (Muggeridge et al., 1990)
TABLE 1
Plasmids Constructed to Express Chimeric Receptors
Plasmid Chimera Amino acid compositiona
pBG48 1*/2/2 Nectin-1a 1–124 fused to nectin-2a 141–479
pBG71 1/2/2 Nectin-1a 1–144 fused to nectin-2a 161–479
pBG39 1/1*/2 Nectin-1a 1–226 fused to nectin-2a 239–479
pBG56 1D/4/4 Nectin-1a 1–124 fused to CD4 201–458
pBG59 1/4/4 Nectin-1a 1–144 fused to CD4 201–458
pBG69 1/1/4/4 Nectin-1a 1–252 fused to CD4 201–458
pBG63 1/1/1/4/4 Nectin-1a 1–337 fused to CD4 201–458
a Amino acid numbering starts with the initiator methionine residue.
he GenBank Accession numbers are AF060231 for nectin-1a,
F058448 for nectin-2a, and M12807 for CD4.with HindIII and inserting the fragment containing the
full-length HSV-2 gD into pcDNA3 digested with HindIII.
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374 GERAGHTY ET AL.Soluble gD:Fc fusion proteins
To produce the gD:Fc proteins, PEAK cells were trans-
fected with one of the gD:Fc-expressing plasmids by the
calcium phosphate method (according to the Edge Bio-
systems protocol). The cells were incubated in DMEM
containing 5% low-Ig calf serum, and 48 h later the
culture supernatant was collected. The culture superna-
tants were clarified by low-speed centrifugation prior to
use and the concentration of gD:Fc protein was deter-
mined by ELISA with reagents that detected the rabbit Fc
region. A full description of the properties of these gD:Fc
proteins will be published elsewhere (A. Fridberg, R. J.
Geraghty, B. Lum, and P. G. Spear, manuscript in prepa-
ration).
Assays for binding of mAbs and gD:Fcs to cells
(CELISA)
CHO-K1 cells were transfected with plasmids ex-
pressing nectin-1a, nectin-2a, CD4, or chimeric recep-
ors or with control plasmid without insert (pcDNA3),
sing LipofectAMINE (Gibco-BRL) as recommended
y the manufacturer. Each well of a 6-well plate re-
eived 5 ml of LipofectAMINE and 1.5 mg of plasmid
DNA. After 24 h, the transfected cells were replated
into 96-well dishes (approximately 4 3 104 cells per
well). The next day, the cells were incubated with
anti-nectin-1 mAbs in 50 ml of phosphate-buffered sa-
line containing 3% bovine serum albumen (PBS/3%
BSA) or with culture supernatants containing one of
the gD:Fc molecules described above and diluted with
PBS/3% BSA. After 30 min at room temperature, the
cells were washed five times with PBS and fixed with
100 ml of 2% formaldehyde–0.2% glutaraldehyde for 10
in at room temperature. The cells were washed three
imes with PBS/3% BSA and incubated with biotinyl-
ted secondary antibodies against rabbit IgG (Sigma)
or the gD:Fc molecules or mouse IgG (Sigma) for the
Abs at a 1:500 dilution in 100 ml PBS/3% BSA for 30
in at room temperature. Following the secondary
ncubation, the cells were washed five times with PBS
nd incubated with AMDEX streptavidin-conjugated
orseradish peroxidase (Amersham) at 1:20,000 dilu-
ion in 100 ml of PBS/3% BSA/0.1% Tween 20 for 30 min
at room temperature. Following tertiary incubation, the
cells were washed five times in PBS/0.1% Tween 20
and incubated with 3,39,5,59-tetramethylbenzidine in
phosphate-citrate buffer according to the manufactur-
er’s instructions (Sigma). At various times after the
addition of substrate, the plates were read at 370 nm
in a Spectra Max 250 ELISA reader. The mAbs used
included R1.302 (Cocchi et al., 1998a) and CK1, CK5,
K6, CK7, CK8, CK10, and CK11 (Krummenacher et al.,
000). Each binds to an epitope in the V domain of
ectin-1.ssay for viral entry
CHO-K1 cells were transfected as described above
nd replated in 96-well plates. The next day the cells
ere exposed to various dilutions of the viruses de-
cribed above, in PBS containing 0.1% glucose and 1%
alf serum. After 6 h, the cells were lysed and b-galac-
tosidase activity was determined, as previously de-
scribed (Montgomery et al., 1996), as a measure of viral
ntry.
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